Sutent side effects - from FDA reports


Summary

In this review, we analyze Sutent side effects by the time on the drug, gender and age of the people who have side effects while taking Sutent. The review is based on 31,184 people who have side effects while taking the drug from FDA, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


Sutent

Sutent has active ingredients of sunitinib malate. It is often used in renal cell carcinoma. (latest outcomes from Sutent 31,359 users)

On Dec, 31, 2017

31,184 people who take Sutent are studied.


Number of reports submitted per year:

Sutent side effects.

Most common side effects over time *:

< 1 month:
  • vomiting
  • thrombocytopenia
  • white blood cell count decreased
  • death
  • weight decreased
  • platelet count decreased
  • yellow skin
  • pyrexia
  • stomatitis
  • disease progression
1 - 6 months:
  • death
  • vomiting
  • weight decreased
  • thrombocytopenia
  • white blood cell count decreased
  • yellow skin
  • pleural effusion
  • disease progression
  • stomatitis
  • metastatic renal cell carcinoma
6 - 12 months:
  • death
  • vomiting
  • weight decreased
  • yellow skin
  • palmar-plantar erythrodysaesthesia syndrome
  • osteonecrosis
  • osteonecrosis of jaw
  • stomatitis
  • thrombocytopenia
  • white blood cell count decreased
1 - 2 years:
  • vomiting
  • death
  • weight decreased
  • osteonecrosis of jaw
  • yellow skin
  • hypertension
  • renal failure
  • disease progression
  • metastatic renal cell carcinoma
  • dehydration
2 - 5 years:
  • death
  • osteonecrosis of jaw
  • acute myocardial infarction
  • neoplasm progression
  • vomiting
  • weight decreased
  • hypertension
  • myocardial infarction
  • palmar-plantar erythrodysaesthesia syndrome
  • thrombocytopenia
5 - 10 years:
  • drug ineffective
  • infection
  • weight decreased
  • second primary malignancy
  • vomiting
  • atrial fibrillation
  • c-reactive protein increased
  • colonic fistula
  • death
  • eosinophil count increased
10+ years:
  • platelet count decreased
not specified:
  • death
  • vomiting
  • weight decreased
  • disease progression
  • diarrhoea
  • yellow skin
  • stomatitis
  • white blood cell count decreased
  • fatigue
  • neoplasm malignant

Most common side effects by gender *:

female:
  • death
  • vomiting
  • weight decreased
  • yellow skin
  • thrombocytopenia
  • white blood cell count decreased
  • stomatitis
  • disease progression
  • diarrhoea
  • nausea
male:
  • death
  • weight decreased
  • vomiting
  • white blood cell count decreased
  • yellow skin
  • disease progression
  • thrombocytopenia
  • stomatitis
  • diarrhoea
  • fatigue

Most common side effects by age *:

0-1:
  • thrombocytopenia
  • death
  • diarrhoea
  • disease progression
  • ventricular tachycardia
2-9:
  • abdominal pain
  • cardiac arrest
  • hair colour changes
  • respiratory failure
  • tongue disorder
  • tumour compression
10-19:
  • weight decreased
  • death
  • weight increased
  • haemangioma
  • neutropenia
  • pneumothorax
  • skin ulcer
  • vomiting
  • ascites
  • bone marrow failure
20-29:
  • death
  • vomiting
  • skin exfoliation
  • nausea
  • demyelination
  • face oedema
  • gastrointestinal stromal tumour
  • mediastinal haemorrhage
  • pneumothorax
  • pulmonary haemorrhage
30-39:
  • death
  • vomiting
  • pleural effusion
  • renal impairment
  • white blood cell count decreased
  • diarrhoea
  • nausea
  • weight decreased
  • yellow skin
  • ascites
40-49:
  • death
  • vomiting
  • yellow skin
  • weight decreased
  • pleural effusion
  • disease progression
  • white blood cell count decreased
  • metastatic renal cell carcinoma
  • thrombocytopenia
  • nausea
50-59:
  • death
  • vomiting
  • weight decreased
  • yellow skin
  • white blood cell count decreased
  • stomatitis
  • thrombocytopenia
  • disease progression
  • nausea
  • fatigue
60+:
  • death
  • weight decreased
  • vomiting
  • white blood cell count decreased
  • stomatitis
  • yellow skin
  • thrombocytopenia
  • diarrhoea
  • nausea
  • platelet count decreased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Are you taking Sutent?

Expand the study to include reports from both FDA and eHealthMe

Sutent side effects from FDA and eHealthMe reports

Related studies

All Sutent side effects from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

On eHealthMe, Sutent (sunitinib malate) is often used to treat metastatic renal cell carcinoma. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:

Questions to the study

More questions >

User posts to the study

More posts >